Small/Micro Cap

Rolling Up the Sleeves

Chris Lahiji | |

The LD Micro Index picked up over 2% last week, while the rest of the indices lagged significantly.

Cogentix to be Acquired by Laborie Medical Technologies for $239 Million

Edward Kim | |

$3.85 per share in cash = 28% premium to CGNT closing price for last 30 days.

Unum Therapeutics Files for $75 Million IPO

Edward Kim | |

Lead candidate in Phase 1 trials for non-Hodgkin lymphoma.

Sorrento Gets FDA Approval for Non-Opioid Patch for Post-Herpetic Neuralgia

Edward Kim | |

12-hour wearable lidocaine relief for post-shingles pain.

DBV Technologies Reports Positive Phase 2 Data for Milk Allergy Treatment

Edward Kim | |

Potential novel skin patch treatment for for gE-mediated cow’s milk protein allergy (CMPA).

Kazia Gets Orphan Drug Designation for Investigational Glioblastoma Multiforme Drug

Edward Kim | |

Glioblastoma multiforme is the most common, most aggressive form of primary brain cancer (Image: Rare Disease Report).

Voyager Therapeutics Signs Alzheimer's Gene Therapy Deal with AbbVie Worth up to $1.1 Billion

Edward Kim | |

$69 million upfront + up to $155 million in preclinical and Phase 1 options + up to $895 million in developmental milestones.

Seattle Genetics to Acquire Cascadian Therapeutics

Edward Kim | |

SGEN adds CASC's late stage breast cancer therapeutic pipeline.

Summit Therapeutics Releases Positive Interim Data on Duchenne Drug

Edward Kim | |

24-week data shows reduced muscle damage and increased utrophin expression.

resTORbio IPO on Deck, Less than a Year After Licensing Clinical Programs from Novartis

Edward Kim | |

Rapid path to Nasdaq for company developing treatments for aging-related diseases.


Symbol Last Price Change % Change






Blockchain in Fintech - Discussion at the EU Parliament

From the recent Blockchain For Europe Summit in Brussels: Panel on Financial Market Infrastructure